Skip to main content

Anna Tate Riegel


Professor of Oncology and Pharmacology


Breast Cancer
General profile


+1 202-687-1479




Univ. Leeds U.K. (First Class Honors) B.S. 1978 Pharmacology
Univ. Leeds U.K. (with distinction) M.S. 1979 Steroid Endocrinology
University of Wisconsin, McArdle Lab Ph.D. 1983 Oncology

Honors & Other Special Scientific Recognition
1980-1982 Fulbright Scholar
1982 James Price Award for Cancer Research
1982-1983 Madison Graduate School Fellow, University of Wisconsin
1984-1985 Damon Runyon-Walter Winchell Post-Doctoral Research Fellow
1990-1992 Pharmaceutical Manufacturer’s Association Foundation Junior Faculty Development Award
1992-1997 Research Career Development Award, NIH

Professional Societies
1991 Member, American Endocrine Society
2002 Member, American Association of Cancer Research

Patents filed/granted
1998 “Use of FGF-BP gene promoter sequences as sensors of drug effects and oncogenic, angiogenic vascular and immune function.” Violaine K. Harris, Anton Wellstein and Anna T. Riegel
Provisional PCT/US99/16544; international 014749.0104

2002 “Coactivators in the diagnosis and treatment of breast cancer.”
Anna T. Riegel, Ronald Reiter and Anton Wellstein, filed.


Download cv.doc


  • PhD (1983) University of Wisconsin, Oncology
  • MS (1979) University of Leeds, UK, Steroid Endocrinology
  • BS (1978) University of Leeds, UK, Pharmacology